Jupiter Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.9M	Sell	491,093 -129,956	-21%	-$3.11M	0.06%	271
2025 Q4	$16.6M	Buy	621,049 +144,732	+30%	+$3.46M	0.13%	180
2025 Q3	$10.2M	Sell	476,317 -160,058	-25%	-$3.79M	0.09%	222
2025 Q2	$13.7M	Buy	636,375 +229,324	+56%	+$4.26M	0.11%	206
2025 Q1	$6.76M	Buy	+407,051	New	+$7.39M	0.06%	254
2024 Q4	–	Sell	-157,457	Closed	-$2.42M	–	384
2024 Q3	$2.42M	Sell	157,457 -903,383	-85%	-$15.1M	0.02%	313
2024 Q2	$17.2M	Sell	1,060,840 -542,934	-34%	-$8.76M	0.16%	175
2024 Q1	$29.7M	Buy	1,603,774 +281,410	+21%	+$6.97M	0.28%	119
2023 Q4	$41.4M	Buy	1,322,364 +46,148	+4%	+$1.1M	0.41%	69
2023 Q3	$26.6M	Buy	1,276,216 +4,932	+0.4%	+$134K	0.29%	99
2023 Q2	$30.4M	Sell	1,271,284 -96,317	-7%	-$2.14M	0.33%	82
2023 Q1	$25.7M	Buy	1,367,601 +277,629	+25%	+$5.29M	0.36%	91
2022 Q4	$17.3M	Buy	1,089,972 +1,012,680	+1,310%	+$15.8M	0.25%	129
2022 Q3	$1.26M	Buy	77,292 +12,273	+19%	+$199K	0.02%	381
2022 Q2	$917K	Buy	+65,019	New	+$1.21M	0.01%	440
2020 Q4	–	Sell	-116,258	Closed	-$4.8M	–	578
2020 Q3	$4.8M	Buy	+116,258	New	+$5.02M	0.05%	304